Skip to main content

Company News

November 28, 2024

With E-Resale, bioMérieux innovates by giving a second life to its instruments

Launched last July, starting with Africa and Middle East, the E-Resale platform allows to purchase and sell second-hand bioMérieux instruments for clinical applications. This is an innovative offer in the field of circular economy and a first on the in vitro diagnostics market.
Discover More

  • January 04, 2023

    bioMérieux establishes Antimicrobial Stewardship Centers of Excellence 

    bioMérieux takes a proactive, partnership-driven approach to combating AMR with diagnostic and data-driven solutions to improve stewardship efforts. To further this goal, bioMérieux created the AMS Centers of Excellence (CoE) designation awarded to hospitals around the world as a sign of a joint commitment to best AMS practices.
    Read more

  • December 08, 2022

    Cell and Gene Therapies: bioMérieux partners with NecstGen

    bioMérieux and NecstGen, collaborate to accelerate the development of Cell and Gene Therapies (CGT) through the provision of ‘state of the art’ and rapid quality and safety testing technologies that will allow safe and effective advanced therapeutics production.
    Read more

  • October 27, 2022

    20 years of collaboration in the fight against infectious diseases.

    For 20 years, bioMérieux and the Hospices Civils de Lyon (HCL) have been collaborating in an innovative public/private research partnership. Joined in 2016 by Claude Bernard Lyon 1 University, the three institutions are working to figure out the mechanisms of immunity in order to develop diagnostic tests.
    Read more

Follow us on Socials for more news!